Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC vs LINK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SEQUENT SCIENTIFIC LINK PHARMA SEQUENT SCIENTIFIC/
LINK PHARMA
 
P/E (TTM) x 178.7 38.8 460.1% View Chart
P/BV x 8.4 1.3 632.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SEQUENT SCIENTIFIC   LINK PHARMA
EQUITY SHARE DATA
    SEQUENT SCIENTIFIC
Mar-24
LINK PHARMA
Mar-24
SEQUENT SCIENTIFIC/
LINK PHARMA
5-Yr Chart
Click to enlarge
High Rs15569 226.0%   
Low Rs7034 204.6%   
Sales per share (Unadj.) Rs54.967.3 81.6%  
Earnings per share (Unadj.) Rs-1.2-3.1 38.7%  
Cash flow per share (Unadj.) Rs1.3-0.7 -172.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.230.9 75.2%  
Shares outstanding (eoy) m249.434.44 5,617.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.10.8 268.4%   
Avg P/E ratio x-94.9-16.8 566.0%  
P/CF ratio (eoy) x88.0-69.5 -126.6%  
Price / Book Value ratio x4.81.7 291.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m28,090228 12,297.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,50655 4,542.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,697299 4,581.3%  
Other income Rs m1106 1,712.0%   
Total revenues Rs m13,807305 4,521.2%   
Gross profit Rs m440-7 -6,772.8%  
Depreciation Rs m61510 5,951.6%   
Interest Rs m4819 5,514.4%   
Profit before tax Rs m-546-19 2,852.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-250-6 4,526.8%   
Profit after tax Rs m-296-14 2,172.6%  
Gross profit margin %3.2-2.2 -147.9%  
Effective tax rate %45.828.9 158.8%   
Net profit margin %-2.2-4.6 47.4%  
BALANCE SHEET DATA
Current assets Rs m8,109115 7,035.7%   
Current liabilities Rs m6,270110 5,697.3%   
Net working cap to sales %13.41.7 770.7%  
Current ratio x1.31.0 123.5%  
Inventory Days Days955 16.5%  
Debtors Days Days89629 14.2%  
Net fixed assets Rs m6,392144 4,431.3%   
Share capital Rs m49944 1,123.3%   
"Free" reserves Rs m5,29493 5,711.8%   
Net worth Rs m5,793137 4,225.3%   
Long term debt Rs m1,42711 13,489.5%   
Total assets Rs m14,620260 5,634.0%  
Interest coverage x-0.1-1.2 11.4%   
Debt to equity ratio x0.20.1 319.3%  
Sales to assets ratio x0.91.2 81.3%   
Return on assets %1.3-1.9 -66.8%  
Return on equity %-5.1-9.9 51.4%  
Return on capital %-0.9-7.1 12.9%  
Exports to sales %1.40-   
Imports to sales %0.60-   
Exports (fob) Rs m188NA-   
Imports (cif) Rs m81NA-   
Fx inflow Rs m1880-   
Fx outflow Rs m810-   
Net fx Rs m1070-   
CASH FLOW
From Operations Rs m3060 -109,267.9%  
From Investments Rs m-594 -1,461.7%  
From Financial Activity Rs m-14-4 353.6%  
Net Cashflow Rs m2320 -77,453.3%  

Share Holding

Indian Promoters % 0.0 51.5 -  
Foreign collaborators % 52.8 0.0 -  
Indian inst/Mut Fund % 16.4 0.0 82,200.0%  
FIIs % 6.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.2 48.5 97.4%  
Shareholders   154,603 6,151 2,513.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SEQUENT SCIENTIFIC With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SEQUENT SCIENTIFIC vs LINK PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SEQUENT SCIENTIFIC vs LINK PHARMA Share Price Performance

Period SEQUENT SCIENTIFIC LINK PHARMA S&P BSE HEALTHCARE
1-Day 1.87% 2.23% 0.61%
1-Month 9.18% 2.21% -0.85%
1-Year 79.76% -10.42% 42.74%
3-Year CAGR 4.33% 6.66% 20.11%
5-Year CAGR 24.68% 24.82% 26.09%

* Compound Annual Growth Rate

Here are more details on the SEQUENT SCIENTIFIC share price and the LINK PHARMA share price.

Moving on to shareholding structures...

The promoters of SEQUENT SCIENTIFIC hold a 52.8% stake in the company. In case of LINK PHARMA the stake stands at 51.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SEQUENT SCIENTIFIC and the shareholding pattern of LINK PHARMA.

Finally, a word on dividends...

In the most recent financial year, SEQUENT SCIENTIFIC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

LINK PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SEQUENT SCIENTIFIC, and the dividend history of LINK PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.